Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial-Reference-Cited by-同舟云学术

Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial

Published:2011-05-06 Issue:8 Volume:54 Page:1985-1991
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Foley J. E.,Bunck M. C.,Möller-Goede D. L.,Poelma M.,Nijpels G.,Eekhoff E. M.,Schweizer A.,Heine R. J.,Diamant M.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.springerlink.com/index/pdf/10.1007/s00125-011-2167-8

Reference14 articles.

1. Ahrén B, Pratley RE, Soubt M, Dunning BE, Foley JE (2008) Clinical measures of islet function: usefulness to characterize defects in diabetes. Curr Diab Rev 4:129–145

2. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D (1984) Diminished beta-cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318–1328

3. Weir GC, Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53(Suppl 3):S16–S21

4. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza R, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110

5. Salehi M, Aulinger BA, D'Alessio DA (2008) Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins. Endocr Rev 29:367–379

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study;PLOS ONE;2023-02-09

2. Development and Validation of Novel RP-HPLC Method for the Simultaneous Determination of Remogliflozin and Vildagliptin in Bulk and in synthetic Mixture;Journal of Pharmaceutical Research International;2021-08-14

3. Evaluating the Evidence behind the Novel Strategy of Early Combination from Vision to Implementation;Diabetes & Metabolism Journal;2020-12-31

4. The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study;Acta Diabetologica;2020-11-13

5. Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective;Diabetes, Obesity and Metabolism;2020-11-09